Three Billion, Continued External Growth... Last Year's Sales Doubled Compared to Previous Year
Three Billion, an artificial intelligence rare disease company, announced on the 11th that its sales doubled last year compared to the previous year, leveraging its global growth.
Based on the pre-audit preliminary settlement, Three Billion recorded sales of 5.8 billion KRW last year, an increase of 112% compared to the previous year.
Following a threefold increase in sales in 2023 compared to the previous year, the company continued to grow rapidly last year.
Last year's operating loss was 7.4 billion KRW, slightly down from 8.4 billion KRW the previous year. Employment growth and facility investments continued to support this growth.
Hot Picks Today
"450,000 Deaths Expected by Early Next Year"... World's Worst-Ever El Nino Forecast Spurs Global Alarm
- "Much Has Changed Since You Left, Please Come Back"... Amazon Surprises by Actively Rehiring Former Employees
- Husband Gave 2 Million Won to His Parents, Only a 100,000 Won Gift to Wife’s Family... Divorce Lawsuit Follows
- "It's Nothing to Kill You"... Seungri Caught on CCTV Swinging Soju Bottle
- 'Terror at 2:40 a.m.'... Suspects Wrecked and Fled After an Hour in Bundang Chinese Restaurant Ordeal
The rare disease genetic testing service showed steady growth in over 70 countries worldwide, driving Three Billion's sales growth. The company's overseas sales ratio exceeds 70%. The company explained that the customer repurchase rate is as high as 80%, indicating strong trust.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
